Neumora Therapeutics unveiled $500 million in capital and a research partnership with Amgen. The startup analyzes neurological data to inform its drug research and development; President and Chief Operating Officer Lori Lyons-Williams said researching psychiatric drugs and neurodegenerative drugs within the same company allows brain insights from one area to inform the other.
ARCH Venture Partners
Kris Engskov — an official in the Bill Clinton White House, a long-time executive with Starbucks and most recently president of senior living provider Aegis Living — is set to lead a new company in the home health care space. “COVID taught us how much can be done from home,” Engskov told Home Health Care …
Interline Therapeutics has technology that shows how proteins interact as communities, paving the way for the discovery of new drugs. CEO Zachary Sweeney, a Denali Therapeutics veteran, said the startup will use the $92 million in funding to advance programs in cancer and inflammatory diseases.